The Medical journal of Australia
-
Randomized Controlled Trial
Single dose v two-dose antenatal anti-D prophylaxis: a randomised controlled trial.
To compare rates of detectability of circulating Rh(D)-immunoglobulin (anti-D) at delivery with single and two-dose antenatal anti-D prophylaxis (RAADP) regimens; to compare compliance with the two regimens. ⋯ The two-dose RAADP schedule currently recommended in Australia provides better protection against Rh(D) sensitisation than a one-dose regimen.